Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
3
60%
Ph phase_1
1
20%
Ph phase_3
1
20%

Phase Distribution

1

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (20.0%)
Phase 23 (60.0%)
Phase 31 (20.0%)

Trials by Status

not_yet_recruiting120%
active_not_recruiting120%
completed360%

Recent Activity

1 active trials
Showing 5 of 5
completedphase_1

Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity

NCT07787728
completedphase_2

Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity

NCT07791524
completedphase_2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity

NCT07791654
active_not_recruitingphase_2

Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight

NCT07791537
not_yet_recruitingphase_3

Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity

NCT07778693

Clinical Trials (5)

Showing 5 of 5 trials
NCT07787728Phase 1

Phase Ib Clinical Study of MWN109 Injection in Participants With Overweight or Obesity

Completed
NCT07791524Phase 2

Phase 2 Study of MWN109 Tablet in Participants With Overweight or Obesity

Completed
NCT07791654Phase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight or Obesity

Completed
NCT07791537Phase 2

Phase 2 Study to Evaluate the Efficacy and Safety of MWN109 Injection in Non-Diabetic Participants With Overweight

Active Not Recruiting
NCT07778693Phase 3

Phase 3 Study of MWN109 Injection in Participants With Overweight or Obesity

Not Yet Recruiting

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5